Archived Press Releases
2010
6/6/2010
PLX4032 Phase 1 Extension Data in Colorectal Cancer Reported
4/20/2010
Plexxikon's PLX3397 Preclinical Data Demonstrate Potential of Novel, "First-in-Class" Cancer Drug
1/8/2010
Plexxikon Announces First Patient Dosed in Phase 3 Trial
2009
10/8/2009
Plexxikon Treats Initial Patient With First-in-Class Drug in Phase 1 Trial
6/1/2009
Plexxikon Announces PLX4032 Phase 1 Data Showing Objective Responses in Metastatic Melanoma Patients
3/19/2009
Plexxikon Receives Key Patents on Novel Compounds for Multiple Programs
1/8/2009
Plexxikon and Roche Enter Second Partnership to Develop PLX5568 for Polycystic Kidney Disease